Retour
Fourchette du Jour
50,19 €
52,55 €
Fourchette 52 Semaines
22,28 €
59,55 €
Volume
5 972 328
Moyenne 50J / 200J
47,06 €
/
32,47 €
Clôture Précédente
51,38 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,2 | 0,4 |
| P/B | 2,3 | 2,9 |
| ROE % | -28,9 | 3,7 |
| Net Margin % | -145,2 | 3,9 |
| Rev Growth 5Y % | -42,5 | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
35,67 €
-30.4%
Low: 17,00 €
High: 63,00 €
BPA Prévisionnel
-6,39 €
CA Est.
2,1 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,66 €
1,98 € – 4,35 €
|
6,7 B | 6 |
| FY2029 |
-0,03 €
-0,05 € – -0,02 €
|
5 B | 10 |
| FY2028 |
-2,90 €
-6,17 € – 0,69 €
|
3,2 B | 15 |
Points Clés
Revenue declined -42,46% annually over 5 years
Debt/Equity of 0,22 — conservative balance sheet
Negative free cash flow of -2,07B
PEG of 0,19 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,23%
Capital efficient — spends only 9,88% of revenue on capex
Croissance
Revenue Growth (5Y)
-42,46%
Revenue (1Y)-39,23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-28,87%
ROIC-21,82%
Net Margin-145,16%
Op. Margin-158,13%
Sécurité
Debt / Equity
0,22
Current Ratio3,29
Interest Coverage0,00
Valorisation
P/E Ratio
-7,18
P/B Ratio2,34
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -39,23% | Revenue Growth (3Y) | -46,72% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -42,46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,94B | Net Income (TTM) | -2,82B |
| ROE | -28,87% | ROA | -22,87% |
| Gross Margin | 55,35% | Operating Margin | -158,13% |
| Net Margin | -145,16% | Free Cash Flow (TTM) | -2,07B |
| ROIC | -21,82% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,22 | Current Ratio | 3,29 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,18 | P/B Ratio | 2,34 |
| P/S Ratio | 10,42 | PEG Ratio | 0,19 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 20,25B | Enterprise Value | 19,57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,94B | 3,20B | 6,85B | 18,88B | 17,74B |
| Net Income | -2,82B | -3,56B | -4,71B | 8,36B | 12,20B |
| EPS (Diluted) | -7,26 | -9,27 | -12,34 | 20,10 | 28,29 |
| Gross Profit | 1,08B | 1,74B | 2,16B | 13,46B | 15,12B |
| Operating Income | -3,07B | -3,95B | -4,24B | 9,42B | 13,30B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,34B | 14,14B | 18,43B | 25,86B | 24,67B |
| Total Liabilities | 3,69B | 3,24B | 4,57B | 6,74B | 10,52B |
| Shareholders' Equity | 8,65B | 10,90B | 13,85B | 19,12B | 14,15B |
| Total Debt | 1,92B | 747,00M | 1,24B | 1,20B | 916,00M |
| Cash & Equivalents | 2,60B | 1,93B | 2,91B | 3,21B | 6,85B |
| Current Assets | 6,54B | 8,10B | 10,33B | 13,43B | 16,07B |
| Current Liabilities | 1,99B | 2,21B | 3,02B | 4,92B | 9,13B |